TickerFactsScreenerDevelopers

Rein Therapeutics, Inc. (RNTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2014: $6.21M2015: $3.77M2016: $20.71M2017: $11.86M2018: $10.63M2019: $5.31M2020: $7.05M2021: $3.60M2022: $5.19M2023: $17.34M2024: $12.87M2025: $3.21M$3.21M
2014Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$3.21M-75.0%
2024$12.87M-25.8%
2023$17.34M+233.8%
2022$5.19M+44.3%
2021$3.60M-48.9%
2020$7.05M+32.7%
2019$5.31M-50.1%
2018$10.63M-10.4%
2017$11.86M-42.7%
2016$20.71M+449.8%
2015$3.77M-39.3%
2014$6.21M—